| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5700282 | Clinical Oncology | 2006 | 7 Pages |
Abstract
Paclitaxel, cisplatin and 5-FU (TCF)-chemoradiation is an active regimen; the current dose schedule tested is associated with unacceptable toxicity, and cannot be recommended for routine clinical use.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
S. Mukherjee, J. Abraham, A. Brewster, R. Hardwick, T. Havard, W. Lewis, C. Askill, J. Manson, G.T. Williams, S.A. Roberts, J. Court, T. Crosby,